Envestnet Portfolio Solutions
HRMY icon

Envestnet Portfolio Solutions’s Harmony Biosciences HRMY Stock Holding History

Envestnet Portfolio Solutions’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$640K Buy
17,566
+787
+5% +$24.8K ﹤0.01% 888
2026
Q1 		$470K Sell
16,779
-1,482
-8% -$48.6K ﹤0.01% 930
2025
Q4 		$683K Buy
18,261
+94
+0.5% +$3.09K ﹤0.01% 922
2025
Q3 		$501K Sell
18,167
-818
-4% -$28.2K ﹤0.01% 1030
2025
Q2 		$600K Buy
+18,985
New +$611K ﹤0.01% 1012

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Portfolio Solutions's HRMY Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Harmony Biosciences (HRMY) stake by 4.7% in Q2 2026, buying an estimated $24.8K and bringing the position to 17,566 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Envestnet Portfolio Solutions first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $683K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Envestnet Portfolio Solutions held 17,566 shares of Harmony Biosciences worth $640K as of Q2 2026.
  • Envestnet Portfolio Solutions bought 787 Harmony Biosciences shares in Q2 2026, an estimated $24.8K.
  • Harmony Biosciences made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #888 holding.
  • Envestnet Portfolio Solutions first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Envestnet Portfolio Solutions's Harmony Biosciences position peaked at $683K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.